Eyal Breitbart

566 citations
37 papers · 455 indexed · h-index 14
Topics
Virus-based gene therapy research (13 papers)Cancer Research and Treatments (11 papers)Angiogenesis and VEGF in Cancer (6 papers)

In The Last Decade

Eyal Breitbart

36 papers receiving 440 citations

Peers

Eyal Breitbart
Comparison fields: 5 of 75
  • Molecular Biology 211
  • Genetics 132
  • Immunology 121
  • Oncology 97
  • Cancer Research 60
Replace Oscar D. Bustuoabad with:
Oscar D. Bustuoabad Argentina
Weixin Lu United States
Hubertus Stockinger Germany
Justina McEvoy United States
H. Rosenbaum United States
AJ Lusis United States
Angela Pitisci Italy
Francesco Turturro United States
Marian Rocha Germany
Kenji Miyadai Japan
Eyal Breitbart relative to Oscar D. Bustuoabad Argentina Oscar D. Bustuoabad's profile →
Citations per field
00.5×5.5×
Oscar D. Bustuoabad · 1×
Citations per year

Countries citing papers authored by Eyal Breitbart

Since Specialization
Citations

This map shows the geographic impact of Eyal Breitbart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Breitbart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Breitbart more than expected).

Fields of papers citing papers by Eyal Breitbart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Breitbart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Breitbart. The network helps show where Eyal Breitbart may publish in the future.

Co-authorship network of co-authors of Eyal Breitbart

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Breitbart. A scholar is included among the top collaborators of Eyal Breitbart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Breitbart. Eyal Breitbart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 1
3 19
4 13
5 16
6 16
7 2
8 13
9 6
10 11
11 16
12 18
13 7
14 3
15 16
16 35
17 40
18 31
19 26
20 11

About Eyal Breitbart

Eyal Breitbart is a scholar working on Biotechnology, Genetics and Immunology, having authored 37 papers that have together received 455 indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Cancer Research and Treatments (11 papers) and Angiogenesis and VEGF in Cancer (6 papers). The work is most often cited by research in Biotechnology (59 citations), Immunology (121 citations) and Biochemistry (31 citations). Eyal Breitbart has collaborated with scholars based in Israel, United States and Russia. Frequent co-authors include Dror Harats, Itzhak Mendel, Niva Yacov, Aviv Shaish, Iris Barshack, Shoshana Greenberger, Nira Varda‐Bloom, Yaël C. Cohen, Israel Hodish and Iris Goldberg. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026